Skip to Main Content

Author Details

Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
2004
81
32
PMIDPaper TitleJournal TitlePublished Year
36629093Prognosis prediction and risk factors for triple-negative breast cancer patients with brain metastasis: A population-based study.Cancer Med2023
36691871Characterization of a germline variant MSH6 c.4001G >⿿C in a Lynch syndrome family.Mol Genet Genomic Med2023
34667028Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.Clin Cancer Res2022
35833951Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.Clin Cancer Res2022
35971132Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.Genome Med2022
33300245Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.Hum Mutat2021
33907319Correction to: Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) variant.Eur J Hum Genet2021
33822432Insertion of an SVA element in MSH2 as a novel cause of Lynch syndrome.Genes Chromosomes Cancer2021
33619332Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant.Eur J Hum Genet2021
34405229A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.J Natl Cancer Inst2021
34635660Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.NPJ Breast Cancer2021
34741162The context-specific role of germline pathogenicity in tumorigenesis.Nat Genet2021
34308366Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.Nat Cancer2021
33169439The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response.Hum Mutat2021
33452952The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer.Breast Cancer Res Treat2021
31444830Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma.Hum Mutat2020
32012241Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.Cancer2020
31794323Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.J Clin Oncol2020
31881335Reliable Clinical MLH1 Promoter Hypermethylation Assessment Using a High-Throughput Genome-Wide Methylation Array Platform.J Mol Diagn2020
33058565Insertion of an Alu-like element in MLH1 intron 7 as a novel cause of Lynch syndrome.Mol Genet Genomic Med2020
32444418Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.Clin Cancer Res2020
32356167Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family.Fam Cancer2020
30643016Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.Cancer Res2019
31648317ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.Blood Adv2019
32775946Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer.JCO Precis Oncol2019
32923861Pathogenic Loss-of-Function Germline <i>TERT</i> Mutations in Patients With Solid Tumors.JCO Precis Oncol2019
30255452A synonymous germline variant PALB2 c.18G&gt;T (p.Gly6=) disrupts normal splicing in a family with pancreatic and breast cancers.Breast Cancer Res Treat2019
30166615Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas.Mod Pathol2019
31323388Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.J Thorac Oncol2019
31175329Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade.Mod Pathol2019
30894706Correction: Toward automation of germline variant curation in clinical cancer genetics.Genet Med2019
30787465Toward automation of germline variant curation in clinical cancer genetics.Genet Med2019
30376427Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.J Clin Oncol2019
30523343Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework.Genet Med2019
28819720Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.Fam Cancer2018
30068732Germline <i>SDHA</i> mutations in children and adults with cancer.Cold Spring Harb Mol Case Stud2018
29872864Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.JAMA Oncol2018
29978187Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.JAMA Oncol2018
30311380Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel.Hum Mutat2018
30311375Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.Hum Mutat2018
30311369Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.Hum Mutat2018
29185120Characterization of a novel germline BRCA1 splice variant, c.5332+4delA.Breast Cancer Res Treat2018
29122777Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.Cancer Discov2018
29293272The emerging significance of secondary germline testing in cancer genomics.J Pathol2018
28555354Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.Fam Cancer2018
28526081Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.BMC Med Genomics2017
30211344Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data.JCO Precis Oncol2017
28873162Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.JAMA2017
28825054Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.JCO Precis Oncol2017
28609363O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.Pancreas2017
  • 1 - 50 of 81

Recommended Authors

Invitae Corporation
Career Start Year 2013
Number of shared co-authors 2
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 13
Invitae Corporation
Career Start Year 2011
Number of shared co-authors 24
University of Oslo
Career Start Year 2007
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 31
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 14
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 21
34Dana-Farber/Brigham and Women's Cancer Center.
Career Start Year 2005
Number of shared co-authors 10
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 7
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 15
University of California
Career Start Year 2003
Number of shared co-authors 0
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 4
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 6
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 9
Lady David Institute for Medical Research, Jewish General Hospital
Career Start Year 2001
Number of shared co-authors 12
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Invitae Corporation
Career Start Year 1998
Number of shared co-authors 6
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 42
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 22
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 9
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 10
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 3
University of British Columbia
Career Start Year 1994
Number of shared co-authors 30
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 30
University of Washington
Career Start Year 1988
Number of shared co-authors 18
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 31
H. Lee Moffitt Cancer Center & Research Institute
Career Start Year 1985
Number of shared co-authors 38
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 25
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 34

Collaborators

Memorial Sloan Kettering Cancer Center
Co-authored papers 23
Memorial Sloan Kettering Cancer Center
Co-authored papers 18
Co-authored papers 16
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Baylor College of Medicine
Co-authored papers 6
University of British Columbia
Co-authored papers 6
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Memorial Sloan-Kettering Cancer Center
Co-authored papers 4
The University of North Carolina at Chapel Hill
Co-authored papers 4
National Institutes of Health
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
QIMR Berghofer Medical Research Institute
Co-authored papers 3
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Co-authored papers 2
The Institute of Cancer Research
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan-Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Boston University
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2